Home   >    CRISPR   >   CRISPR Enzymes

LwCas13a, Active

Recombinant full-length Leptotrichia wadei Cas13a protein with a His tag expressed in E. coli.


50 ug 100 ug 250 ug 1000 ug

$ 140


Cas13a is an RNA-guided RNA endonuclease that belongs to the class 2 type VI CRISPR-Cas system (1). Cas13a possesses both RNA recognition and cleavage activities and cleaves RNA through conserved basic residues within its two HEPN domains (2). Activated Cas13a also induces collateral cleavage of nearby non-targeted RNAs in a nonspecific manner (3). This property of the Cas13a enzyme has been leveraged for the development of sensitive and robust nucleic acid detection tools with applications in both basic research and therapeutics development (4).

Accession Number:


Recombinant protein stored in 50 mM Tris-HCL pH7.5, 600 mM NaCl, 2 mM DTT, 10% glycerol.


1. East-Seletsky A, et al. 2016. Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection. Nature. 538:270–3. 2.

2. Abudayyeh O, et al. 2016. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science. 353:5573 3.

3. Zhang J, You Y. 2020. CRISPR-Cas13a system: A novel approach to precision oncology. Cancer Biol Med. 17(1):6-8.

4. Patchsung M, et al. 2020. Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA. Nat Biomed Eng. 4(12):1140-1149.

There are no related publications available for this product.


Acute Respiratory Distress Syndrome , Cardiovascular Disease, Cellular Stress, COVID19, Gastrointestinal Diseases , Infectious Diseases , Inflammation, Lung Diseases , Metabolic Disorder, Neurobiology, severe acute respiratory syndrome coronavirus 2 , Virology